Staged Percutaneous Coronary Intervention (PCI) for Multivessel STEMI Patients?
DOI:
https://doi.org/10.2015/hc.v5i1%20Sup.342Abstract
Primary percutaneous coronary intervention (PCI) is the treatment of choice for patients with ST-elevation myocardial infarction (STEMI) since it results in greater patency of the infarct-related artery (IRA) and lower rates of re-infarction, stroke and death when compared with fibrinolysis alone. Multivessel disease (MVD) occurs in 40% to 65% of patients with STEMI. Is it possible for an aggressive multivessel percutaneous revascularization strategy to afford advantages in greater myocardial salvage and avoidance of staged procedures, with subsequent savings in compounded procedural risks? ...(excerpt)Downloads
Issue
Section
License
Authors who publish with this journal agree to the following terms:a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
